Emtricitabine Withdrawn Phase 2 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03074786Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)